Actavis Inc recalled Vancomycin Hydrochloride Capsules, USP, 250 mg due to subpotent drug hazards, the Food and Drug Administration said on Feb. 12, 2015. The recall affects 29,405 cartons distributed nationwide.
How to tell if you have it
- Brand: Actavis
- Product: Vancomycin Hydrochloride Capsules, USP, 250 mg
- Packaging: 2 x 10 count blister pack
- NDC: 0591-3561-15
- Lot codes: 3109554 (Exp 3/31/2015), 3111457 (Exp 3/31/2015), 3112973 (Exp 7/31/2015), 3114262 (Exp 6/30/2015), 3114076 (Exp 12/31/2015), 3115889 (Exp 12/31/2015), 3116033 (Exp 12/31/2015)
The hazard
The recalled Vancomycin Hydrochloride Capsules are subpotent drugs. The FDA record does not report specific incidents or injuries associated with this recall.
Context
GovInfoNow's records show Actavis Inc has 13 other recalls on record since March 22, 2013. Other recent recalls of similar products include Actavis Levofloxacin Eye Drops Recall (Feb. 7, 2017), Actavis Glipizide 2.5mg Tablets Recall (Jan. 30, 2017), and Actavis Albuterol Inhaler Recall (Jan. 12, 2017). Other recent recalls of similar products include Baxter Vancomycin Injection Recalls (Aug. 6, 2026) and Teva Isotretinoin Capsules 30mg Recall (Jan. 12, 2026).